Tango Therapeutics, Inc. (TNGX) /
The debt of Tango Therapeutics, Inc. over the past 6 years
Chart Tango Therapeutics, Inc.: liquid cash, total debt, net cash, fiscal 2020–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Tango Therapeutics, Inc. had liquid cash of $343.14M and total debt of $0: net cash of $343.14M. It had more liquid cash than debt at all 6 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $343.14M* | $0 | $343.14M |
| 2024ended Dec 31, 2024 | $257.92M* | $0 | $257.92M |
| 2023ended Dec 31, 2023 | $336.88M* | $0 | $336.88M |
| 2022ended Dec 31, 2022 | $366.13M* | $0 | $366.13M |
| 2021ended Dec 31, 2021 | $485.25M* | $0 | $485.25M |
| 2020ended Dec 31, 2020 | $190.32M* | $0 | $190.32M |
Fiscal years as Tango Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Tango Therapeutics, Inc.
- The revenue of Tango Therapeutics, Inc.
- The profitability of Tango Therapeutics, Inc.
- The cash flow of Tango Therapeutics, Inc.
- All of Tango Therapeutics, Inc.'s financials, charted
Companies of a similar size
- MWAMueller Water Products, Inc.
- TNETTRINET GROUP, INC.
- PRIMPrimoris Services Corporation
- BNLBroadstone Net Lease, Inc.
- SMGScotts Miracle-Gro Co
Not investment advice. This page shows what Tango Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.